Moderna sues pfizer and biontech for infringing patents central to moderna's innovative mrna technology platform

Complaints to be filed in both united states and germany alleging that pfizer and biontech's covid-19 vaccine comirnaty® unlawfully infringes patents moderna filed between 2010 and 2016 moderna not seeking removal of comirnaty® from market or injunction against future sales company not pursuing monetary damages on sales to the 92 low- and middle-income countries in the gavi covax advance market commitment (amc 92) cambridge, ma / accesswire / august 26, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today is filing patent infringement lawsuits against pfizer and biontech in the united states district court for the district of massachusetts and the regional court of dÜsseldorf in germany. moderna believes that pfizer and biontech's covid-19 vaccine comirnaty® infringes patents moderna filed between 2010 and 2016 covering moderna's foundational mrna technology.
MRNA Ratings Summary
MRNA Quant Ranking